Sử dụng kháng sinh trong điều trị nhiễm khuẩn huyết tại khoa nhiễm khuẩn tổng hợp - Bệnh viện Hữu nghị Đa khoa Nghệ An=Use of antibiotics in the treatment of bacteremia at the department of general infectious diseases

Sử dụng kháng sinh trong điều trị nhiễm khuẩn huyết tại khoa nhiễm khuẩn tổng hợp - Bệnh viện Hữu nghị Đa khoa Nghệ An=Use of antibiotics in the treatment of bacteremia at the department of general infectious diseases - Nghe An General Friendship Hospital

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Thị Soa Đặng, Thị Hồng Hạnh Nguyễn, Thị Thủy Vũ

Ngôn ngữ: vie

Ký hiệu phân loại:

Thông tin xuất bản: Y học cộng đồng, 2023

Mô tả vật lý: tr.45947

Bộ sưu tập: Metadata

ID: 477606

Thêm vào giỏ

Khảo sát thực trạng và đánh giá tính hợp lý, an toàn sử dụng kháng sinh trên bệnh nhân nhiễm khuẩn huyết. Phương pháp nghiên cứu: Nghiên cứu mô tả cắt ngang tiến hành trên 38 hồ sơ bệnh án của bệnh nhân được chẩn đoán nhiễm khuẩn huyết điều trị tại Khoa Nhiễm khuẩn tổng hợp – Bệnh viện Hữu Nghị đa khoa Nghệ An từ tháng 1 đến tháng 3 năm 2023. Kết quả nghiên cứu: Tuổi trung bình là 66,9 ± 20,7
tỉ lệ nam/nữ = 1,7
81,6% bệnh nhân có nguy cơ nhiễm khuẩn cao. Các kháng sinh được sử dụng nhiều nhất trong mẫu nghiên cứu là piperacillin/ tazobactam, meropenem, doxycyclin và amikacin tỉ lệ lần lượt là 39,5%
39,5%
44,7% và 50%. 94,7% bệnh nhân trong mẫu nghiên cứu được lựa chọn kháng sinh hợp lí với phân tầng nguy cơ nhiễm khuẩn. 100% bệnh nhân sử dụng liều phù hợp và không có biến cố bất lợi xảy ra trong quá trình bệnh nhân sử dụng kháng sinh. Tương tác thuốc xảy ra trên 28,9% bệnh nhân trong đó chủ yếu là tương tác mức độ trung bình (26,3%). Kết luận: Kháng sinh điều trị nhiễm khuẩn huyết chủ yếu là nhóm Betalactam, hầu hết là lựa chọn kháng sinh và liều dùng phù hợp với khuyến cáo của Hội Hồi sức tích cực Việt Nam.Surveying the current situation of antibiotic use and assessing the rationality and safety of antibiotic use in patients with Bloodstream infection. Research methods: A cross-sectional description of 38 medical records of patients with BSI treated at the at the Department of General Infectious - Nghe An General Hospital from January to March 2023. Results: Mean age 66.9 ± 20.7
male/female = 1.7
81.6% of patients were at high risk of infection. The most used antibiotics in the study sample were piperacillin/tazobactam, meropenem, doxycycline and amikacin, respectively 39.5%
39.5%
44.7% and 50%. 94.7% of the patients in the study had a reasonable choice of antibiotics with risk stratification for infection. 100% of patients used the appropriate dose and no adverse events occurred during the patient's antibiotic use. Drug interactions occurred in 28.9% of patients, which was mainly moderate interactions (26.3%). Conclusion: Antibiotics to treat sepsis are mainly Betalactam group, most antibiotic choices and dosages are consistent with the recommendations of the Vietnam Intensive Care Association.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR